Adeona expands and enhances zinc-based product applicant portfolio Adeona Pharmaceuticals.

‘I anticipate providing guidance as Adeona techniques their promising zinc-based item candidates through advancement.’ Zinc for Prevention of Infection in the Elderly Adeona has entered into an contract with Dr. Prasad that delivers the Company with access to medical data from a 50 patient, 12-month, randomized, double-blind, placebo-controlled clinical trial that evaluated preventing infection in patients age 55 to 87 who had been treated with an oral zinc therapy or coordinating placebo. The medical trial was conducted by Dr. Prasad and co-investigators. The principal endpoint of the medical trial was the rate of infections between the placebo and zinc treated groups.Another 40 men were tested 4-6 months later on, and 65 % of these semen samples tested positive. The newest group of 43 guys were tested between seven and nine a few months after sign onset, and 26 % had Ebola within their semen, the investigators found. We’ve seen this type of thing with additional illnesses – – the compartmentalization of a virus, Fischer stated. The virus looks for parts of the body that the patient’s disease fighting capability can’t easily reach, what we call immune-privileged sites.

You may also like